Genfit (GNFT) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Genfit Analyst Ratings
Benzinga12:36 ET · Ratings
European Equities Traded in the US as American Depositary Receipts Decrease Friday
MT NewswiresSep 20 11:07 ET
H.C. Wainwright Maintains Genfit(GNFT.US) With Buy Rating, Maintains Target Price $13
Moomoo NewsSep 20 09:33 ET · Ratings
Buy Rating Affirmed for Genfit SA on Financial Milestones and Promising Drug Approvals
TipRanksSep 20 08:35 ET · Ratings
Market-Moving News for September 20th
BenzingaSep 20 08:29 ET
Tenon TNON Patents; Genfit GNFT Earnings
BioPharmCatalystSep 20 07:52 ET

Comments

Trytosaveabit

Jun 11 06:52

News released late in to AM last evening

$Genfit (GNFT.US)$ Ipsen, Genfit Medicine Is Cleared by FDA for Rare Liver Disorder
The drug will be called Iqirvo, Ipsen said in a statement Monday. (Bloomberg) -- Ipsen SA and partner Genfit SA won US regulators’ clearance for the first new treatment option in eight years for patients with a rare liver disease.
The US Food and Drug Administration approved the medicine, elafibranor, for adults with primary biliary cholangitis, an autoimmune disease in whi...

3

Meltyy

Jun 11 03:48

🔔 FDA PDUFA Update…

🚨 1 AdCom & 3 PDUFA decisions this week:
$Genfit (GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD (IPSEY.US)$ : 🤔
⇨ Elafibranor
‣ Primary biliary cholangitis
‣ PDUFA date: 6/10/24
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Kevzara (sarilumab)
‣ Polyarticular juvenile idiopathic arthritis
‣ PDUFA date: 6/10/24
$Bristol-Myers Squibb (BMY.US)$ : 🤔
⇨ Augtyro™ (Repotrectinib)
‣ PDUFA date: 6/15/24 (sNDA)
🗓️ Last week’s PDUFAs:
$GlaxoSmithKline (GSK.US)$ : Approved 6/7 🎉
⇨ Arexvy
‣ Respiratory s...

10

1

Jaguar8

Jun 10 16:35

Added info on FDA News

$Genfit (GNFT.US)$
Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis - 10 June 2024 - 12 mins read
Iqirvo® (elafibranor) 80 mg tablets is the first new medicine approved in nearly a decade for the treatment of the rare liver disease called primary biliary cholangitis
Approval based on positive Phase III ELATIVE trial data Primary biliary cholangitis impacts approximately 100,000 people in the US and is g...

1

Jaguar8

Jun 10 16:29

NEWS

$Genfit (GNFT.US)$
GENFIT Says Iqirvo Is First-ever Drug Developed In-house By Company To Achieve FDA Approval; Expects To Receive Milestone Payments From Ipsen

1

Meltyy

Jun 7 03:39

🚨 June PDUFAs

» 15+ upcoming FDA decisions to watch: 👀 👇
$GlaxoSmithKline (GSK.US)$ : Arexvy
$Genfit (GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD (IPSEY.US)$ : Elafibranor
$Eli Lilly and Co (LLY.US)$ : Donanemab - AdCom meeting 🗓️
$Regeneron Pharmaceuticals (REGN.US)$ : Kevzara (sarilumab)
$Bristol-Myers Squibb (BMY.US)$ : Augtyro™ (Repotrectinib)
$Geron (GERN.US)$ : Imetelstat
$Merck & Co (MRK.US)$ : V116
$Amgen (AMGN.US)$ : BLINCYTO (blinatumomab)
$Sarepta Therapeutics (SRPT.US)$ : ELEVIDYS
$Merck & Co (MRK.US)$ : KEYTRUDA ...

16

GNFT Genfit

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target